- Home
- MESO vs EXK Comparison
MESO vs EXK Comparison
Compare MESO & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESO
- EXK
- Stock Information
- Founded
- MESO 2004
- EXK 1981
- Country
- MESO Australia
- EXK Canada
- Employees
- MESO N/A
- EXK N/A
- Industry
- MESO Biotechnology: Biological Products (No Diagnostic Substances)
- EXK Precious Metals
- Sector
- MESO Health Care
- EXK Basic Materials
- Exchange
- MESO Nasdaq
- EXK Nasdaq
- Market Cap
- MESO 1.1B
- EXK 1.3B
- IPO Year
- MESO N/A
- EXK N/A
- Fundamental
- Price
- MESO $10.18
- EXK $4.50
- Analyst Decision
- MESO Strong Buy
- EXK Strong Buy
- Analyst Count
- MESO 4
- EXK 4
- Target Price
- MESO $11.50
- EXK $6.83
- AVG Volume (30 Days)
- MESO 215.6K
- EXK 6.5M
- Earning Date
- MESO 08-28-2024
- EXK 11-05-2024
- Dividend Yield
- MESO N/A
- EXK N/A
- EPS Growth
- MESO N/A
- EXK N/A
- EPS
- MESO N/A
- EXK N/A
- Revenue
- MESO $5,902,000.00
- EXK $225,927,000.00
- Revenue This Year
- MESO $66.05
- EXK $10.36
- Revenue Next Year
- MESO $348.27
- EXK $63.82
- P/E Ratio
- MESO N/A
- EXK N/A
- Revenue Growth
- MESO N/A
- EXK N/A
- 52 Week Low
- MESO $1.61
- EXK $1.42
- 52 Week High
- MESO $12.18
- EXK $5.67
- Technical
- Relative Strength Index (RSI)
- MESO 54.91
- EXK 45.10
- Support Level
- MESO $10.00
- EXK $4.38
- Resistance Level
- MESO $10.98
- EXK $5.04
- Average True Range (ATR)
- MESO 0.59
- EXK 0.28
- MACD
- MESO 0.06
- EXK -0.06
- Stochastic Oscillator
- MESO 47.92
- EXK 28.06
About MESO Mesoblast Limited
Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The company has three producing silver-gold mines in Mexico: the Guanacevi Mine in Durango, the Bolanitos Mine in Guanajuato and the El Compas Mine in Zacatecas. It also has three exploration projects in northern Chile: Aida project, Paloma project and the Cerro Marquez project.